Peripheral Oxidative Stress Biomarkers in Spinocerebellar Ataxia Type 3/Machado–Joseph Disease
ObjectivesSpinocerebellar ataxia type 3/Machado–Joseph disease (SCA3/MJD) is a polyglutamine disorder with no current disease-modifying treatment. Conformational changes in mutant ataxin-3 trigger different pathogenic cascades, including reactive oxygen species (ROS) generation; however, the clinica...
Main Authors: | Adriano M. de Assis, Jonas Alex Morales Saute, Aline Longoni, Clarissa Branco Haas, Vitor Rocco Torrez, Andressa Wigner Brochier, Gabriele Nunes Souza, Gabriel Vasata Furtado, Tailise Conte Gheno, Aline Russo, Thais Lampert Monte, Raphael Machado Castilhos, Artur Schumacher-Schuh, Rui D’Avila, Karina Carvalho Donis, Carlos Roberto de Mello Rieder, Diogo Onofre Souza, Suzi Camey, Vanessa Bielefeldt Leotti, Laura Bannach Jardim, Luis Valmor Portela |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2017-09-01
|
Series: | Frontiers in Neurology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/article/10.3389/fneur.2017.00485/full |
Similar Items
-
State biomarkers for Machado Joseph disease: Validation, feasibility and responsiveness to change
by: Gabriel Vasata Furtado, et al. -
Curva de Crescimento Usando Modelo Misto: Uma Aplicação na Progressão da Doença de Machado-Joseph
by: Lisiane Hauser, et al.
Published: (2009-04-01) -
Long-term progression of clinician-reported and gait performance outcomes in hereditary spastic paraplegias
by: Diana Maria Cubillos Arcila, et al.
Published: (2023-09-01) -
Differences in spontaneous speech fluency between Parkinson's disease and spinocerebellar ataxia type 3
by: Vanessa Brzoskowski dos Santos, et al.
Published: (2023-05-01) -
A model for the dynamics of expanded CAG repeat alleles: ATXN2 and ATXN3 as prototypes
by: Lucas Schenatto Sena, et al.
Published: (2023-11-01)